KPMG in Precision Medicine

Example Oncologist Question

Oncologists expect the rapid uptake of liquid biopsy for patient monitoring in the next 5 years if technical hurdles are overcome and sufficient evidence is generated. Data from 4 of the 13 countries below. To understand more about trends across all markets, please contact us.

Number of patients per 100 new cancer patients treated where liquid biopsy tests are ordered for monitoring / progression purposes, today and in 5 years (n = 548)¹

Notes: (1) Data may disproportionately represent HCPs at larger AMCs and national cancer centers with better funding/access and treat patients of higher socioeconomic status.

Example Pathologist Question

Pathologists expect the use of IVD NGS kits to grow rapidly, but this is not a uniform trend across all markets. Data from 4 of the 13 countries below. To understand more about trends across all markets, please contact us.

Number of NGS tests performed using IVD designated kits per 100 NGS tests performed on clinical cancer samples, today and in 5 years (n = 334)